Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06667245
Starting soon Observational

Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster

NCT06667245 · tracked via the Priya Life Science Spain tracker
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase
Observational
Started
2024-11-04
Last updated
2024-10-31

Condition(s) studied

Herpes ZosterQuality of LifeImmunization; Infection

Study summary

Title: Impact on quality of life and disease burden in adults with herpes zoster

Prospective cohort study for the primary objective and the secondary objectives (1 and 2) and retrospective cohort study for the secondary objective 3.

Disease or disorder under study: Patients with a herpes zoster (HZ) diagnosis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
1 Prospective cohort study Inclusion criteria Patients \> 18 years of age who are to be immunized against HZ Exclusion criteria: * Pregnant women * Patients with altered level of consciousness (dementia and others) who do not complete the questionnaires * Patients who do not wish to participate in the study 5.2 Retrospective cohort study Inclusion criteria Adults \>18 years of age with a diagnosis of HZ in the CMBD from 2012 to 2023 at the Jiménez Díaz Foundation hospital. Since the international classification of diseases changed from ICD 9 to ICD 10 in 2106, the codes to be used for the inclusion of patients in the study are described below. ICD 9 053 Herpes zoster Includes: * Herpes zoster * Zone 053.0 With meningitis 053.1 With other central nervous system complications * 053.10 With unspecified nervous system complications * 053.11 Geniculate herpes zoster or Herpetic geniculate ganglionitis * 053.12 Postherpetic trigeminal neuralgia * 053.13 Postherpetic polyneuropathy * 053.14 Herpes zoster myelitis * 053.19 Other 053.2 With ophthalmic complications * 053.20 Herpes zoster dermatitis of eyelid or Herpes zoster ophthalmicus * 053.21 Herpes zoster keratoconjunctivitis * 053.22 Herpes zoster iridocyclitis zoster * 053.29 Other 053.7 With other specific complications * 053.71 Otitis externa due to herpes zoster * 053.79 Other 053.8 With unspecified complications 053.9 Herpes zoster without complication Herpes zoster NOS ICD 10 B02 Herpes zoster Includes: * herpes * zona B02.0 Encephalitis due to herpes zoster Meningoencephalitis due to zoster B02.1 Meningitis due to herpes zoster B02.2 Herpes zoster with other nervous system involvement * B02.21 Postherpetic geniculate ganglionitis * B02.22 Postherpetic trigeminal neuralgia * B02.23 Postherpetic polyneuropathy * B.02.24 Myelitis Postherpetic myelitis * B02.29 Other postherpetic nervous system involvement * B02.3 Ocular herpes zoster * B02.30 Ocular herpes zoster, unspecified * B02.31 Herpes zoster conjunctivitis * B02.32 Herpes zoster iridocyclitis * B02.33 Herpes zoster keratitis * B02.34 Herpes zoster scleritis * B02.39 Other herpes zoster eye disease * B02.7 Disseminated herpes zoster * B02.8 Herpes zoster with other complications * B02.9 Uncomplicated herpes zoster * B02.39 Herpes zoster otitis externa NEOM Exclusion criteria: Patients who are vaccinated against HZV

Primary outcome measure(s)

  • Quality of life of patients with a history of herpes zoster who attend the immunization unit of the Jiménez Díaz Foundation University Hospital. — Data will be collected for 1 year and then analyzed to respond to the outcomes
    Measuring the quality of life of patients with a history of herpes zoster who attend the immunization unit of the Jiménez Díaz Foundation University Hospital.

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario Fundación Jiménez Díaz Madrid Spain

More Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials in Spain

Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis Recruiting
External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis Recruiting
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry Recruiting
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis. Starting soon
Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients Recruiting

Other trials for the same condition

EMG Analysis in ABI: Motor Imagery and Action Recruiting
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. Recruiting
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project Active, not recruiting
Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization Recruiting
Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06667245 on ClinicalTrials.gov ↗ ← All trials in Spain